Trial Profile

Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD).

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lithium; Valproic acid
Indications Bipolar disorders
Focus Pharmacogenomic; Therapeutic Use
Acronyms PGBD

Most Recent Events

09 Jun 2020 Biomarkers information updated
16 Nov 2011 Planned End Date changed from 1 Jan 2016 to 1 May 2016 as reported by European Clinical Trials Database.
16 Nov 2011 Additional lead trial centre identified as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com